Characteristic | HCC, n = 99 | CCC, n = 13 |
---|---|---|
Age (y) | ||
<50 | 29 (29.3) | 1 (7.7) |
≥50 | 70 (70.7) | 12 (92.3) |
Sex | ||
Male | 78 (78.8) | 10 (76.9) |
Female | 21 (21.2) | 3 (23.1) |
Etiology* | ||
Hepatitis B | 79 (79.8) | 4 (30.8) |
Hepatitis C | 8 (8.1) | 2 (15.4) |
Alcohol | 8 (8.1) | 2 (15.4) |
Other | 5 (5.0) | 5 (38.4) |
Child–Pugh class | ||
A | 89 (89.9) | 12 (92.3) |
B | 10 (10.1) | 1 (7.7) |
EGOG performance | ||
0 | 65 (65.7) | 8 (61.5) |
1 | 27 (27.2) | 3 (23.1) |
2 | 7 (7.1) | 2 (15.4) |
Tumor size† (cm) | ||
≥1, <2 | 7 (7.8) | 0 (0) |
≥2, <5 | 42 (46.7) | 4 (30.8) |
≥5 | 41 (45.5) | 9 (69.2) |
Tumor number† | ||
1 | 46 (51.1) | 5 (38.5) |
2 | 11 (12.2) | 0 (0) |
3 | 3 (3.3) | 0 (0) |
≥4 | 30 (33.4) | 8 (61.5) |
Tumor type† | ||
Well defined | 78 (86.7) | 6 (46.2) |
Ill defined | 12 (13.3) | 7 (53.8) |
Portal/hepatic vein invasion† | ||
No | 63 (70.0) | 7 (53.8) |
Yes | 27 (30.0) | 6 (46.2) |
Tumor differentiation‡ | ||
I | 9 (9.8) | — |
II | 51 (55.4) | — |
III | 29 (31.6) | — |
IV | 3 (3.3) | — |
α-fetoprotein (ng/mL) | ||
<20 | 43 (43.4) | — |
20–400 | 28 (28.3) | — |
>400 | 28 (28.3) | — |
Modified UICC stage | ||
I | 5 (5.1) | 0 (0) |
II | 37 (37.3) | 3 (23.1) |
III | 16 (16.2) | 3 (23.1) |
IVa | 13 (13.1) | 3 (23.1) |
IVb | 28 (28.3) | 4 (30.7) |
BCLC stage | ||
Very early | 5 (5.1) | — |
Early | 16 (16.3) | — |
Intermediate | 35 (35.7) | — |
Advanced | 42 (42.9) | — |
Terminal | 1 (1.0) | — |
↵* One patient had both hepatitis B virus and hepatitis C virus.
↵† Among 99 HCC patients, 9 patients had only distant metastases without primary liver lesion after previous resection and 90 patients had primary HCC.
↵‡ Edmonson–Steiner grade: 7 of 90 patients with primary HCC had inappropriate biopsy specimen for evaluation of pathologic grade, and 92 patients (83 primary HCC and 9 metastatic HCC) were finally evaluated.
ECOG = Eastern Cooperative Oncology Group.
Data in parentheses are percentages.